Related Experiment Video
Updated: Jun 20, 2025

10:55
Purification of Ubiquitinated p53 Proteins from Mammalian Cells
Published on: March 21, 2022
2.1K
GRAIL1 Stabilizes Misfolded Mutant p53 through a Ubiquitin Ligase-Independent, Chaperone Regulatory Function
Paramita Ray1, Sangeeta Jaiswal2, Daysha Ferrer-Torres2
1Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan.
Molecular Cancer Research : MCR
|July 17, 2024
Summary
Researchers found a new way to degrade mutant p53, a protein driving esophageal cancer. A novel peptide targets heat shock protein 40/DNAJ, inhibiting its chaperone activity to reduce cancer cell survival.
Area of Science:
- Molecular Biology
- Oncology
- Biochemistry
Background:
- TP53 mutations are common in esophageal adenocarcinoma (EAC), leading to protein stabilization, poor prognosis, and therapy resistance.
- The E3 ubiquitin ligase RNF128 (GRAIL) isoform 1 stabilizes mutant p53 during Barrett's esophagus progression to EAC.
- The mechanism by which GRAIL stabilizes mutant p53 was previously unknown.
Purpose of the Study:
- To elucidate the mechanism by which GRAIL stabilizes mutant p53.
- To identify a novel therapeutic strategy targeting mutant p53 stabilization in EAC.
Main Methods:
- Biochemical and cell biology studies were performed.
- Interaction between GRAIL and DNAJ was investigated.
- Overexpression of a GRAIL fragment (Frag-J) and a cell-permeable peptide (Pep-J) were used to inhibit DNAJ-Hsp70 co-chaperone activity.
- Effects on cell survival and organoid growth were assessed.
Main Results:
- GRAIL possesses a DNAJ binding domain (315-PMCKCDILKA-325).
- This interaction modulates DNAJ chaperone activity, influencing misfolded mutant p53 stability.
- Frag-J and Pep-J degraded misfolded mutant p53, reduced survival of EAC and dysplastic Barrett's esophagus cells, and inhibited patient-derived organoid growth.
- Pep-J's effects were comparable to simvastatin.
Conclusions:
- A novel, ubiquitin ligase-independent, chaperone-regulating domain in GRAIL was identified.
- A first-in-class peptide (Pep-J) was synthesized that degrades misfolded mutant p53.
- This peptide demonstrates translational potential for treating EAC and related conditions.
Related Concept Videos
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Regulation of the Unfolded Protein Response
2.4K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.4K
The Unfolded Protein Response
4.5K
The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
4.5K
Export of Misfolded Proteins out of the ER
3.6K
After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
3.6K
Covalently Linked Protein Regulators
6.8K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
6.8K
Molecular Chaperones and Protein Folding
17.9K
The native conformation of a protein is formed by interactions between the side chains of its constituent amino acids. When the amino acids cannot form these interactions, the protein cannot fold by itself and needs chaperones. Notably, chaperones do not relay any additional information required for the folding of polypeptides; the native conformation of a protein is determined solely by its amino acid sequence. Chaperones catalyze protein folding without being a part of the folded protein.
The...
The...
17.9K

